The Wall Street conference, i.e. the most important event in the Polish capital market, was held between 25 and 27 November 2020. This time it was organized on-line.
The conference is a meeting place for individual investors and capital market-related entities. Tens of lectures by best domestic experts, panel discussions and economic debates are held during the three days of the conference.
The event is organized by the Individual Investors Association (Stowarzyszenie Inwestorów Indywidualnych, SII) – the largest investor organization in Poland, which currently brings together over 16 thousand investors. More than 10 thousand of them decided to take part in the event, which translated into the large attendance figures.
The Bioceltix presentation, delivered by Paweł Wielgus – Member of the Company’s Management Board, gathered an audience of more than 100 participants. Several dozen questions were asked on the investor chat. The crowning point of the conference was our representative’s participation in the debate on building a state-of-the-art economy through effective cooperation between the public and the private sectors.
2019? It’s been a good year for Bioceltix. A victory in the Start-Up Challenge coupled with participation in accelerator programs as well as several important congresses, conferences and rankings. A lot has happened over the past year and the next 12 months look even more exciting. Want to know ...Article
Mamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ligaments and joint inflammation to kidney disease. Poles have accomplishments when it comes to utilizing stem cells in animal treatment. PLN 5.1 ...Article
Business Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing biopharmaceuticals for dogs, cats and horses. How is his company improving treatments for animals suffering from degenerative joint or autoimmune diseases? ...Article
My Company Polska has selected the 25 hottest and best startups – and we’re among them! The stem-cell-based pharmaceuticals, which Bioceltix is developing, are a safer and more effective alternative to traditional chemical-based pharmaceuticals currently on the market. Bioceltix was ...Article
Rzczpospolita: The Wroclaw-based biotech, which is working on breakthrough biopharmaceuticals intended for animals, has received additional financing in the amount of 5.1M PLN. Thanks to the grant Bioceltix, a startup, will begin working on a new project aimed at developing a stem-cell-based ...Article
2019? It’s been a good year for Bioceltix. A victory in the Start-Up Challenge coupled with participation in accelerator programs as well as ...Read full
Mamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ...Read full
Business Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing ...Read full